What does the future hold for the Cancer Drugs Fund? Since 2010, the fund has had £200m a year to spend on drugs and has treated 60,000 patients, but many feel it has outstayed its welcome
When the government created the Cancer Drugs Fund (CDF) in 2010 to pay for cancer drugs rejected by the National Institute for Care and Health Excellence (Nice), it was intended as a short-term stopgap until a longer-term solution to the problem of evaluating and funding cancer drugs for terminally ill patients could be developed.
The fund, which was given £200m a year to spend on drugs, was set up in a context of media stories about cancer patients being denied life-extending drugs. Since then, 60,000 patients have received drug treatments funded by the CDF. Although initially welcomed by cancer charities, many feel it has outstayed its welcome. Continue reading... The Guardian
No comments:
Post a Comment